These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34406914)

  • 1. Protecting adults at risk of pneumococcal infection and influenza from exposure to SARS-CoV-2.
    McIntosh EDG; Feemster K; Rello J
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-7. PubMed ID: 34406914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collateral benefits on other respiratory infections during fighting COVID-19.
    Chan KS; Liang FW; Tang HJ; Toh HS; Yu WL
    Med Clin (Barc); 2020 Sep; 155(6):249-253. PubMed ID: 32586667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.
    Amin-Chowdhury Z; Aiano F; Mensah A; Sheppard CL; Litt D; Fry NK; Andrews N; Ramsay ME; Ladhani SN
    Clin Infect Dis; 2021 Mar; 72(5):e65-e75. PubMed ID: 33196783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporally Associated Invasive Pneumococcal Disease and SARS-CoV-2 Infection, Alaska, USA, 2020-2021.
    Newell K; Fischer M; Massey S; Orell L; Steinberg J; Tompkins M; Castrodale L; McLaughlin J
    Emerg Infect Dis; 2023 Sep; 29(9):1765-1771. PubMed ID: 37506683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial.
    Chen H; Huang Z; Chang S; Hu M; Lu Q; Zhang Y; Wang H; Xiao Y; Wang H; Ge Y; Zou Y; Cui F; Han S; Zhang M; Wang S; Zhu X; Zhang B; Li Z; Ren J; Chen X; Ma R; Zhang L; Guo X; Luo L; Sun X; Yang X
    Vaccine; 2022 Aug; 40(36):5322-5332. PubMed ID: 35931636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement.
    Blasi F; Di Pasquale M; Gramegna A; Viale P; Iacobello C; Gori A; Tumbarello M; Esposito S; Richeldi L; Bassetti M
    Respir Med; 2021 Dec; 190():106674. PubMed ID: 34788734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Upper Respiratory Streptococcus pneumoniae Colonization With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Adults.
    Parker AM; Jackson N; Awasthi S; Kim H; Alwan T; Wyllie AL; Baldwin AB; Brennick NB; Moehle EA; Giannikopoulos P; Kogut K; Holland N; Mora-Wyrobek A; Eskenazi B; Riley LW; Lewnard JA
    Clin Infect Dis; 2023 Apr; 76(7):1209-1217. PubMed ID: 36401872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal carriage in children with COVID-19.
    Aykac K; Ozsurekci Y; Cura Yayla BC; Evren K; Lacinel Gurlevik S; Oygar PD; Yucel M; Karakoc AE; Alp A; Cengiz AB; Ceyhan M
    Hum Vaccin Immunother; 2021 Jun; 17(6):1628-1634. PubMed ID: 33449815
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in vaccination uptake against pneumococcal disease, influenza, and coronavirus disease 2019 (COVID-19) before and after a Head and Neck cancer diagnosis.
    Eiberg MF; Rezahosseini O; Bukan KB; Charlotte Arp B; Le VB; Ahmad F; Howitz M; Lendorf M; Friborg J; Lindegaard B; Harboe ZB
    Vaccine; 2024 Aug; 42(20):125972. PubMed ID: 38789370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities in Influenza, Pneumococcal, COVID-19 Vaccine Coverage in High-Risk Adults Aged 19 to 64 Years in Southeastern Minnesota, 2010-2021.
    Felzer JR; Montgomery AJ; LeMahieu AM; Finney Rutten LJ; Juhn YJ; Wi CI; Jacobson RM; Kennedy CC
    Chest; 2024 Jul; 166(1):49-60. PubMed ID: 38342164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave?
    Sticchi L; Taramasso L; Di Biagio A; Olobardi D; Icardi G; Bassetti M
    Hum Vaccin Immunother; 2021 Jun; 17(6):1664-1665. PubMed ID: 33180669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal carriage among high-risk adults in a country with nonmandatory pneumococcal vaccination during the coronavirus disease 2019 pandemic.
    Ngamprasertchai T; Rattanaumpawan P; Kaewkungwal J; Phisalprapa P; Chongtrakool P; Kerdsin A; Luvira V; Thaipadungpanit J; Kajeekul R; Srisompong J; Yincharoen P; Chokephaibulkit K; Lawpoolsri S
    J Infect Public Health; 2023 Jul; 16(7):1102-1108. PubMed ID: 37220711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza and pneumococcal vaccinations are not associated to COVID-19 outcomes among patients admitted to a university hospital.
    Pastorino R; Villani L; La Milia DI; Ieraci R; Chini F; Volpe E; Barca A; Fusco D; Laurenti P; Ricciardi W; Boccia S
    Vaccine; 2021 Jun; 39(26):3493-3497. PubMed ID: 34020813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France.
    Rybak A; Levy C; Angoulvant F; Auvrignon A; Gembara P; Danis K; Vaux S; Levy-Bruhl D; van der Werf S; Béchet S; Bonacorsi S; Assad Z; Lazzati A; Michel M; Kaguelidou F; Faye A; Cohen R; Varon E; Ouldali N
    JAMA Netw Open; 2022 Jun; 5(6):e2218959. PubMed ID: 35763298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of SARS-CoV-2 vaccination resulting from the COVID-19 pandemic with regard to the uptake of influenza virus, pneumococcal, and herpes zoster adult vaccination - a narrative literature review.
    Kłoda K; Mierzecki A; Mastalerz-Migas A; Babicki M
    Ann Agric Environ Med; 2023 Dec; 30(4):587-594. PubMed ID: 38153058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of respiratory viral infections on nasopharyngeal pneumococcal colonization dynamics in children.
    Howard LM; Grijalva CG
    Curr Opin Infect Dis; 2024 Jun; 37(3):170-175. PubMed ID: 38437245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of influenza vaccine on response to vaccination with pneumococcal vaccine in HIV patients.
    Ranieri R; Veronelli A; Santambrogio C; Pontiroli AE
    AIDS Res Hum Retroviruses; 2005 May; 21(5):407-9. PubMed ID: 15929703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association between Influenza and Pneumococcal Vaccinations and SARS-Cov-2 Infection: Data from the EPICOVID19 Web-Based Survey.
    Noale M; Trevisan C; Maggi S; Antonelli Incalzi R; Pedone C; Di Bari M; Adorni F; Jesuthasan N; Sojic A; Galli M; Giacomelli A; Molinaro S; Bianchi F; Mastroianni C; Prinelli F; Group OBOTEW
    Vaccines (Basel); 2020 Aug; 8(3):. PubMed ID: 32842505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced protective responses to a serotype-independent pneumococcal vaccine when combined with an inactivated influenza vaccine.
    Babb R; Chen A; Ogunniyi AD; Hirst TR; Kara EE; McColl SR; Alsharifi M; Paton JC
    Clin Sci (Lond); 2017 Jan; 131(2):169-180. PubMed ID: 27885052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.